Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
4.670
-0.350 (-6.97%)
Oct 22, 2025, 11:58 AM EDT - Market open
Aethlon Medical Market Cap
Aethlon Medical has a market cap or net worth of $3.44 million as of October 22, 2025. Its market cap has decreased by -43.55% in one year.
Market Cap
3.44M
Enterprise Value
622.75K
1-Year Change
-43.55%
Ranking
Category
Stock Price
$4.67
Market Cap Chart
Since July 13, 2015, Aethlon Medical's market cap has decreased from $68.00M to $3.44M, a decrease of -94.94%. That is a compound annual growth rate of -25.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2025 | 1.30M | -89.17% |
| Dec 31, 2024 | 12.00M | 118.18% |
| Dec 29, 2023 | 5.50M | -12.70% |
| Dec 30, 2022 | 6.30M | -77.97% |
| Dec 31, 2021 | 28.60M | -4.35% |
| Dec 31, 2020 | 29.90M | 2,035.71% |
| Dec 31, 2019 | 1.40M | -95.27% |
| Dec 31, 2018 | 29.60M | 73.10% |
| Dec 29, 2017 | 17.10M | -47.38% |
| Dec 30, 2016 | 32.50M | -37.14% |
| Dec 31, 2015 | 51.70M | -23.97% |
| Jul 13, 2015 | 68.00M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 717.80B |
| Johnson & Johnson | 462.11B |
| AbbVie | 408.76B |
| UnitedHealth Group | 330.91B |
| AstraZeneca | 259.08B |
| Novartis AG | 254.71B |
| Novo Nordisk | 245.28B |
| Abbott Laboratories | 221.98B |